fashion -WSS

fashion

author：fashion 2025-10-01 18:45:15 - browse：4567

a doctor wraps a smart watch around a patient's wrist — Adobe

As pharma companies wrestle with how and when to use wearables and other digital technologies to measure how their experimental drugs impact patients, clinical research giant Icon has acquired HumanFirst, which helps companies answer exactly those sorts of questions.

Founded in 2017, HumanFirst maintains a meticulously organized library of digital measurement tools, their underlying evidence, and information about how they have been used in clinical trials. Called Atlas, the platform is designed so that a trial sponsor can research what tools are available to measure things like physical activity or sleep for many commonly studied diseases. CEO Andy Coravos said that robust intelligence can help developers move more quickly and avoid mistakes that require costly changes to trial protocols.

Following the acquisition, HumanFirst will be another offering for Icon, which earned $8 billion last year running clinical trials for pharmaceutical companies and other related services. As of 2021, HumanFirst had raised $15 million in venture capital funding, and the decision to sell to Icon for an undisclosed amount comes as some big drug companies are reevaluating their approach to digital technologies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Telehealth for opioid use disorder is lifesaving

WSS

Gut bacteria may contribute to kidney autoimmunity, study finds

Drug companies' payments and gifts affect physicians' prescribing

New weight loss drugs vying to be the next Wegovy or Mounjaro

FDA panel endorses Alnylam’s heart drug — after picking it apart

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Oral obesity drug from Viking Therapeutics hits key early target

leisure time

fashion

entertainment

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Four alarming medical procedures we’re glad history forgot

Alkermes shareholders re

FDA proposes changes to key medical devices approval pathway

ChatGPT in medicine: STAT answers readers' burning questions

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Affirmative action in medical school literally saved lives

Generate Biomedicines machine learning biotech raises $273M

Jerome Adams on the need for new antivirals for Covid

Scientific mystery highlights the blind spots in genomics databases

focus

Medicare Advantage 2025 payments will dip, Biden administration says

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Harvard scientists, with Google, unveil the most detailed brain map ever

Harvard scientists, with Google, unveil the most detailed brain map ever

Regeneron agrees to White House price limits on anti

Regeneron agrees to White House price limits on anti

focus

leisure time

leisure time

hotspot